Skip to content
sellWeak cluster of 3

Dan Karlin sold $25k of DFTX

Chief Medical Officer at Mind Medicine (MindMed) Inc.. 6,774 shares at an average of $3.63, traded Dec 26, 2023, filed Dec 26, 2023.

Warning score
30
Value
$25k
6,774 shares
Holdings after
365,030
-2% from before
From 52-week low
+81%
low $2.14, close $3.87
From 52-week high
-22%
high $4.93, as of Dec 26, 2023

Score components

  • Role
    Officer
    +15
  • Trade size
    $25k at market
    0
  • Share of holdings sold
    Sold 1.8% of holdings
    0
  • Cluster
    3 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

DFTXOct 12, 2026 · close 35.20
Since filing Dec 26, 2023: +809.6%SPY +68.9% · excess +740.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-23-073078, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 26, 2023SOpen-market sale
Common Shares
-6,774$3.63$25k365,030Dec 26, 2023

Related signals

Other insiders at Mind Medicine (MindMed) Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
45Moderate
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Robert Barrow
Chief Executive Officer
$1.2M
31,550 shares
-1%
27Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Brandi Roberts
Chief Financial Officer
$123k
3,377 shares
-1%
28Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Mark Sullivan
Chief Legal Officer
$514k
14,051 shares
-3%
20Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Matthew T. Wiley
Chief Commercial Officer
$113k
3,097 shares
-1%
26Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Dan Karlin
Chief Medical Officer
$397k
10,853 shares
-1%
26Weak
DFTXsell10b5-1
Mind Medicine (MindMed) Inc.
Robert Barrow
Chief Executive Officer
$722k
19,023 shares
-1%
45Moderate
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Robert Barrow
Chief Executive Officer
$1.3M
29,208 shares
-3%
21Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Matthew T. Wiley
Chief Commercial Officer
$129k
2,867 shares
-2%
28Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Brandi Roberts
Chief Financial Officer
$136k
3,013 shares
-1%
27Weak
DFTXsell 510b5-1
Mind Medicine (MindMed) Inc.
Dan Karlin
Chief Medical Officer
$452k
10,035 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dan Karlin sold $25k of DFTX | InsiderTell